A clinical trial to study the effect of redefining active phase of labour from 4cm to 5cm of cervical dilatation (WHO 2018 guideline ) with minimal intervening the process of labour continuing at its natural pace without compromising feet-maternal outcome.
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Registration Number
- CTRI/2021/02/031429
- Lead Sponsor
- Dr Anshika Tandon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Non-high risk nulliparous women of age between 18 to 35 years.
Height equal to or >145 cm.
Singleton live intrauterine pregnancy.
Vertex with occipito-anterior position
No medical or surgical complications, obstetrical complication and pelvic pathology.
Women with the average gynaecoid pelvis, spontaneous onset of labour pains & given consent for the study.
The patient will be considered once they enter the active phase as per group allocation.
Multipara
Malpresentation
Multifetal pregnancy
Women with premature rupture of membranes (if any) of more than 24 hours duration.
The patient who was previously allocated groups on admission but required intervention in the latent phase.
Any obstetrical complications like GDM, pre-eclampsia, contracted pelvis, cholestatic jaundice etc.
Medical disorders like cardiac, renal, hepatic disease, hypertension, DM, thyroid disorder.
Pelvic pathologies like ovarian cyst, fibroid, any previous uterine surgery, etc.
Presence of congenital fetal malformation like anencephaly, hydrocephalus, etc.
Small for gestation age (birth weight <10 percentile) or large for gestation age baby (birth weight >90 percentile).
Precipitate labour.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of labour: <br/ ><br>i.e. active phase to delivery <br/ ><br>Need for intervention: <br/ ><br>Indications for intervention: <br/ ><br>Mode of delivery:Timepoint: 48 HOURS i.e 2 days
- Secondary Outcome Measures
Name Time Method eonatal outcome: <br/ ><br>Apgar at 1&5min: <br/ ><br>Resuscitative measures used: <br/ ><br>NICU admission & diagnosis: <br/ ><br>Maternal outcome: <br/ ><br> Intrapartum complications: <br/ ><br> Postpartum complications:Timepoint: 5 days